CollPlant Biotechnologies (CLGN) Profit After Tax (2017 - 2026)
CollPlant Biotechnologies (CLGN) reported Profit After Tax of -$3.1 million for Q1 2026, down 313.29% on a YoY basis from $1.5 million in Q1 2025, and up 3.43% quarter-over-quarter from -$3.2 million in Q4 2025.
CollPlant Biotechnologies (CLGN) Profit After Tax (2017 - 2026) Analysis & Trends
CollPlant Biotechnologies has reported Profit After Tax for 10 years, with the latest figure at -$3.1 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 313.29% year-over-year to -$3.1 million; the trailing twelve-month figure through Mar 2026 stood at -$6.4 million (up 66.72% YoY), and the FY2025 full-year result was -$11.5 million, up 30.83% from the prior year.
- Profit After Tax for Q1 2026 stood at -$3.1 million, up from -$3.2 million in the prior quarter.
- The five-year high for Profit After Tax was $5.8 million in Q2 2023, with the low at -$29.3 million in Q4 2024.
- Historically, Profit After Tax has averaged -$1.5 million across 5 years, with a median of $1.5 million in 2025.
- Annual changes were most pronounced in 2022 — Profit After Tax surged 241.05% — and 2026, when it sank 313.29%.
- CollPlant Biotechnologies' Profit After Tax stood at -$4.4 million in 2022, then slumped by 112.43% to -$9.3 million in 2023, then sank by 213.83% to -$29.3 million in 2024, then jumped by 89.07% to -$3.2 million in 2025, then gained by 3.43% to -$3.1 million in 2026.
- The last three Profit After Tax figures came in at -$3.1 million (Q1 2026), -$3.2 million (Q4 2025), and -$3.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -56.74 Mn |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | -3.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.10 Mn |
| Dec 31, 2025 | -3.21 Mn |
| Sep 30, 2025 | -3.48 Mn |
| Jun 30, 2025 | 3.35 Mn |
| Mar 31, 2025 | 1.45 Mn |
| Dec 31, 2024 | -29.34 Mn |
| Sep 30, 2024 | 4.33 Mn |
| Jun 30, 2024 | 4.21 Mn |
| Mar 31, 2024 | 4.20 Mn |
| Dec 31, 2023 | -9.35 Mn |
| Sep 30, 2023 | 4.38 Mn |
| Jun 30, 2023 | 5.76 Mn |
| Mar 31, 2023 | 3.72 Mn |
| Dec 31, 2022 | -4.40 Mn |
| Sep 30, 2022 | -4.38 Mn |
| Jun 30, 2022 | 4.29 Mn |
| Mar 31, 2022 | -3.86 Mn |
| Dec 31, 2021 | -3.77 Mn |
| Sep 30, 2021 | -3.08 Mn |
| Jun 30, 2021 | -3.04 Mn |